

Author: McClure Jennifer B.
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.20, Iss.4, 2006-01, pp. : 281-291
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Nicotine replacement therapy (NRT) is an effective treatment for smoking cessation, but as with all such pharmacotherapies, the majority of smokers who use NRT products do not stop smoking or remain abstinent long term. Treatment outcome is affected by a range of individual-specific factors, as well as the pharmacokinetic profile of each NRT formulation. This has led to speculation that abstinence rates could be improved if NRT treatments were individually tailored to best match each individual's needs and preferences. There are also populations for whom special product and dosage considerations are warranted to maximise treatment safety.This paper reviews the rationale for NRT treatment, standard dose recommendations and recommendations for how to best match NRT treatment to the specific needs of individual smokers. We also review emerging evidence that genetic profiling may one day be a useful consideration for tailoring NRT treatment.
Related content




Pharmacogenetics and Smoking Cessation with Nicotine Replacement Therapy
By Ray Riju Schnoll Robert A. Lerman Caryn
CNS Drugs, Vol. 21, Iss. 7, 2007-01 ,pp. :



